Pharmaceutical composition for preventing and treating red body diseases of shrimps

A composition and drug technology, applied in the directions of antibacterial drugs, antiviral agents, pharmaceutical formulations, etc., can solve the problems of unsatisfactory treatment effect, temporary cure, residual drug toxicity, etc. The effect of increasing appetite and increasing shrimp vitality

Inactive Publication Date: 2011-08-03
仙桃市魏氏生物工程有限责任公司
View PDF2 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] The invention mainly solves the technical problems that the traditional prevention and treatment drugs for the red body disease of prawns treat the symptoms but not the root cause, the treatment effect is not ideal, and the drug poison remains in the shrimp after treatment.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Pharmaceutical composition for preventing and treating red body diseases of shrimps

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0020] Example 1: Cortex Moutan, Artemisia annua, Scutellaria baicalensis, Comfrey, Anemarrhena, Gardenia, Scrophulariaceae, and Radix Radix were respectively pulverized, and passed through a 120-mesh sieve to obtain drug powder; the above powders were respectively put into an oven to dry, and dried Dry at 80°C for 30 minutes; take out 70 parts of dried peony bark powder, 20 parts of Artemisia annua powder, 80 parts of Scutellaria baicalensis powder, 4 parts of comfrey powder, 50 parts of Anemarrhena powder, 10 parts of gardenia powder, and Scrophulariaceae powder 20 parts are respectively poured into the mixer according to the said proportion, and the composition of the present invention can be obtained after thorough mixing.

Embodiment 2

[0021] Example 2: Cortex Moutan, Artemisia annua, Scutellaria baicalensis, Comfrey, Anemarrhena, Gardenia, Scrophulariaceae, and Radix Radix were respectively pulverized, and passed through a 120-mesh sieve to obtain drug powder; the above powders were respectively put into an oven to dry, and dried Dry at 80°C for 30 minutes; take out 5 parts of dried Moutan bark powder, 150 parts of Artemisia annua powder, 4 parts of Scutellaria baicalensis powder, 70 parts of comfrey powder, 2 parts of Anemarrhena powder, 100 parts of gardenia powder, and Scrophulariaceae powder 150 parts are respectively poured into the mixer according to the said proportion, and the composition of the present invention is obtained after thorough mixing.

Embodiment 3

[0022] Example 3: Cortex Moutan, Artemisia annua, Scutellaria baicalensis, Comfrey, Anemarrhena, Gardenia, Scrophulariaceae, and Radix Radix were respectively pulverized, and passed through a 120-mesh sieve to obtain drug powder; the above powders were respectively put into an oven to dry, and dried Dry at 80°C for 30 minutes; take out dried peony bark powder 40 parts, Artemisia annua powder 60 parts, Scutellaria baicalensis powder 50 parts, comfrey powder 40 parts, Anemarrhena powder 25 parts, gardenia powder 50 parts, Scrophulariaceae powder 120 copies, 10 copies of Banlangen.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention provides a pharmaceutical composition for preventing and treating red body diseases of shrimps, which is prepared from the following components in parts by weight: 35 parts of cortex moutan radicis, 80 parts of sweet wormwood, 45 parts of scutellaria baicalensis, 40 parts of lithospermum, 25 parts of rhizoma anemarrhenae, 50 parts of gardenia, 70 parts of radix scrophulariae and 30 parts of radix isatidis. In the invention, pharmaceutical components are fine-selected, reasonable compatibility is realized, and the synergetic effect of respective components is developed; therefore, the pharmaceutical composition has good effects of clearing heat and removing toxin, and the immunity of shrimp bodies can be obviously enhanced; the pharmaceutical composition can play the role of preventing the reproduction of viruses through inhibiting the synthesis of nucleic acid and lipoprotein; after the pharmaceutical composition is administrated, the energy of the shrimps is increased, the number of red bodies is reduced, the orexia of the shrimps is increased, the immunity of organisms is improved, the death rate of illed shrimps can be quickly reduced, and the economical benefit of a cultivation farmer is sufficiently ensured. Meanwhile, as the pharmaceutical composition is a pure Chinese herbal preparation, the pharmaceutical composition does not have any side effect, and pharmaceutical residual cannot be formed in shrimp bodies; therefore, the quality of the shrimp product can be effectively ensured.

Description

technical field [0001] The invention relates to a medicine for aquatic products, in particular to a medicine composition for preventing and treating red body disease of shrimps. Background technique [0002] Shrimp red body disease can generally be divided into bacterial red body disease and viral red body disease. Bacterial red body disease: the appendages turn yellow or red, especially the swimming feet, and the whole body turns red under the light of a flashlight at night. The activity of the sick shrimp is weakened, swimming slowly on the water surface of the pool or sinking to the bottom, sometimes rotating or swimming vertically, unresponsive, loss of appetite or stop eating. The gills of sick shrimp turn yellow and the shell becomes hard. The hepatopancreas has no obvious variation, the body has no black spot symptoms, the hemolymph becomes thinner, the blood cells become less, and the fluid coagulates slowly or does not coagulate. [0003] Viral red body syndrome: ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K36/8964A61P31/04A61P31/12
Inventor 魏光春
Owner 仙桃市魏氏生物工程有限责任公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap